fr
Article scientifique
Anglais

New approaches to the pharmacotherapy of neuropathic pain

Publié dansExpert review of clinical pharmacology, vol. 1, no. 5, p. 683-693
Date de publication2008
Résumé

Pain is one of the most debilitating symptoms that presents with neuropathy. Neuropathic pain syndrome is a challenge to treat and, even with appropriate evidence-based treatment, only a 40% reduction of symptoms can be achieved in approximately half of patients. Furthermore, efficient doses are often difficult to obtain because of adverse effects. These observations underline that the treatment of neuropathic pain is still an unmet medical need. New approaches to the pharmacotherapy of neuropathy embrace different lines of work, including a fundamental mechanism-based approach, a clinical mechanism-based approach and an evidence-based approach. Moreover, interindividual variability in drug response, and genetic polymorphism in particular, is an emerging aspect to consider. Together with reviewing recent evidence-based guidelines as well as briefly discussing genetic polymorphisms that may influence the individual responses to treatments, this article will focus on what a mechanism-based approach is bringing to the clinical setting, on the perspective in fundamental research and on the difficulty of bridging the gap between fundamental notions and positive clinical outcomes.

Citation (format ISO)
BESSON, Marie et al. New approaches to the pharmacotherapy of neuropathic pain. In: Expert review of clinical pharmacology, 2008, vol. 1, n° 5, p. 683–693. doi: 10.1586/17512433.1.5.683
Identifiants
ISSN du journal1751-2433
515vues
0téléchargements

Informations techniques

Création19/11/2014 11:47:00
Première validation19/11/2014 11:47:00
Heure de mise à jour14/03/2023 22:29:48
Changement de statut14/03/2023 22:29:48
Dernière indexation16/01/2024 15:18:57
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack